Email
Dangers of Anti-Obesity Drugs Evident in Meridia Recall
After more than a decade, Abbott Laboratories has finally withdrawn Meridia (Sibutramine), the controversial anti-obesity drug. This was due to strong pressure from the Food and Drug Administration (FDA), backed by the results of a clinical study which showed that Meridia increased the risk of heart attack and stroke by 16 percent. Meridia works by [...]
